Market Cap 15.34M
Revenue (ttm) 0.00
Net Income (ttm) -12.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 128,100
Avg Vol 918,166
Day's Range N/A - N/A
Shares Out 2.29M
Stochastic %K 39%
Beta 1.89
Analysts Strong Sell
Price Target $17.67

Company Profile

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a fixed dose combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for burn and ocular pain; and...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 620 8655
Website: dwtx.com
Address:
44 Milton Avenue, Alpharetta, United States
PremarketAnalysis
PremarketAnalysis Oct. 7 at 1:51 PM
$DWTX showing sustained bid support with buy surge detected near 6.80.. structure tightening as buyers step in.. watching for clean push over 7.00 to confirm trend extension Momentum Feed: https://premarketanalysis.com/#momentum=DWTX
0 · Reply
DARKP00L
DARKP00L Oct. 7 at 1:03 PM
$DWTX 08:49 on Oct. 07 2025 Dogwood Therapeutics Announces Its CMO Will Present An Overview Of The Halneuron Pain Management Research Program At 19th Annual Pain Therapeutics Summit On October 14, 2025 #tradeideas
0 · Reply
DARKP00L
DARKP00L Oct. 7 at 12:54 PM
$DWTX 08:49 on Oct. 07 2025 Dogwood Therapeutics Announces Its CMO Will Present An Overview Of The Halneuron Pain Management Research Program At 19th Annual Pain Therapeutics Summit On October 14, 2025 #tradeideas
0 · Reply
Cyberwolf2077
Cyberwolf2077 Oct. 7 at 12:46 PM
$DWTX Tbh outlook looks good and their research is needed
0 · Reply
basti22
basti22 Oct. 6 at 6:47 PM
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:36 PM
$BLMZ $DGNX $CEP $DWTX Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 3 at 2:38 PM
$DWTX Current Stock Price: $6.90 No options data available.
0 · Reply
Drugtrade
Drugtrade Oct. 2 at 7:27 PM
$DWTX if ur in this forna quick trade then use a stop loss for chrisakes
0 · Reply
ByBi
ByBi Oct. 2 at 2:21 PM
$DWTX You guys realize that all the outstanding shares are owned by the same people, right ? Right ??
0 · Reply
MadeJustForThis
MadeJustForThis Oct. 2 at 2:06 PM
$DWTX This is why you read before Panic Selling. Perfect Dip Opportunity
0 · Reply
Latest News on DWTX
Dogwood Therapeutics, Inc. - Special Call

Sep 29, 2025, 12:17 PM EDT - 8 days ago

Dogwood Therapeutics, Inc. - Special Call


Dogwood Therapeutics, Inc. Regains Nasdaq Compliance

Apr 3, 2025, 9:00 AM EDT - 6 months ago

Dogwood Therapeutics, Inc. Regains Nasdaq Compliance


PremarketAnalysis
PremarketAnalysis Oct. 7 at 1:51 PM
$DWTX showing sustained bid support with buy surge detected near 6.80.. structure tightening as buyers step in.. watching for clean push over 7.00 to confirm trend extension Momentum Feed: https://premarketanalysis.com/#momentum=DWTX
0 · Reply
DARKP00L
DARKP00L Oct. 7 at 1:03 PM
$DWTX 08:49 on Oct. 07 2025 Dogwood Therapeutics Announces Its CMO Will Present An Overview Of The Halneuron Pain Management Research Program At 19th Annual Pain Therapeutics Summit On October 14, 2025 #tradeideas
0 · Reply
DARKP00L
DARKP00L Oct. 7 at 12:54 PM
$DWTX 08:49 on Oct. 07 2025 Dogwood Therapeutics Announces Its CMO Will Present An Overview Of The Halneuron Pain Management Research Program At 19th Annual Pain Therapeutics Summit On October 14, 2025 #tradeideas
0 · Reply
Cyberwolf2077
Cyberwolf2077 Oct. 7 at 12:46 PM
$DWTX Tbh outlook looks good and their research is needed
0 · Reply
basti22
basti22 Oct. 6 at 6:47 PM
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:36 PM
$BLMZ $DGNX $CEP $DWTX Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 3 at 2:38 PM
$DWTX Current Stock Price: $6.90 No options data available.
0 · Reply
Drugtrade
Drugtrade Oct. 2 at 7:27 PM
$DWTX if ur in this forna quick trade then use a stop loss for chrisakes
0 · Reply
ByBi
ByBi Oct. 2 at 2:21 PM
$DWTX You guys realize that all the outstanding shares are owned by the same people, right ? Right ??
0 · Reply
MadeJustForThis
MadeJustForThis Oct. 2 at 2:06 PM
$DWTX This is why you read before Panic Selling. Perfect Dip Opportunity
0 · Reply
ByBi
ByBi Oct. 2 at 1:59 PM
$DWTX Block the noise Bullish as fock They are no amateur
0 · Reply
bobbydoles
bobbydoles Oct. 2 at 1:52 PM
$DWTX if you lost money here you deserved, daily add anything under $10 $CIGL $ASBP $TNMG LFG
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 2 at 1:15 PM
$DWTX (-8.3% pre) Dogwood Therapeutics (DWTX) files for 28.04M share offering by selling stockholders https://ooc.bz/l/79203
0 · Reply
MadeJustForThis
MadeJustForThis Oct. 2 at 11:33 AM
$DWTX Filing seems Bullish😎
0 · Reply
bobbydoles
bobbydoles Oct. 2 at 11:29 AM
$DWTX this filing is bullish, this is biotech
0 · Reply
TTXB
TTXB Oct. 2 at 4:40 AM
$DWTX This is an affiliated company of the CK Group under Li Ka-shing, the well-known richest man in Hong Kong. It is not a fraudulent stock. It is believed that the conversion of this common stock will only be carried out when there is significant positive news.
1 · Reply
Movingpawn0
Movingpawn0 Oct. 2 at 2:43 AM
$DWTX called “sell the news” kinda vibe
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 2:25 AM
Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watching $VERI $PEPG $DWTX $GPRO
1 · Reply
jonws
jonws Oct. 2 at 2:15 AM
$DWTX Here's the schedule for the future. 1. Effective disclosure of s-3 documents released today (Notice of Effectiveness document should appear on EDGAR site) 2. Proxy submission (disclosure of shareholders' meeting date) 3. Holding a special shareholders' meeting (approval of selling rights of 28 million shares) What's important here is, The effective disclosure is usually (10–30 days) When submitting the Proxy after it takes effect (1-3 days) It usually takes about 20 to 40 days to hold a special shareholders' meeting after submitting the proxy What's the point If all three of these procedures are completed, we'll start selling 28 million shares Normally, all three of these procedures must be completed by the end of November or early December Therefore, it overlaps with the announcement of FDA approval In addition, there is a clause called "beneficial ownership limitation", so it is impossible to sell in bulk at once Of course, there will be shareholders who don't sell.
2 · Reply
jonws
jonws Oct. 2 at 12:55 AM
$DWTX If there's no good news, I think it's going to be down the right all the way through December. Under $5. Why did the company do this without a plan? The order was wrong. They should have released good news after this announcement. Most importantly, the FDA announcement in December will have a low success rate.
0 · Reply
jonws
jonws Oct. 2 at 12:52 AM
$DWTX Q4) "What is the actual impact on the stock price?" The market usually values this **'RISEL S-3 + Large convertible equity'** as a strong overhang. However, this is a good thing because it is a resell, not a live ammunition (cash) procurement, so it is not a signal that "the company sells it because it needs urgent money." The actual impact of the stock price is the disclosure of the effective date -> approval of the general shareholders' meeting -> the seller's will In other words, there's still a long way to go Q5) "If you have good news (pipeline), will it be neutralized?" possibility If the performance is good, there can be supply and demand that absorbs overhang as an "opportunity." Conversely, if it fails/delays, all of this could translate into insider selling and be tight
0 · Reply
jonws
jonws Oct. 2 at 12:51 AM
$DWTX Am I right to understand? Q1) "Are you going to sell it right from today?" Not yet. This document is in the "filed" phase. Only when the SEC declares "effective" will it become legal to sell it as this S-3. Q2) "Still, what can you pour out right away?" About 61.5 million shares (~26.8% of the current OS) already issued as common stock are "immediate" volumes that could be on the market immediately upon effect. Calculated: 211,383 + 10,568 + 191,017 + 191,017 + 5,234 + 5,234 + 100 = 614,553 weeks. Q3) "Can I switch and throw the remaining 27.43 million weeks at any time?" No. All **Preferred shares → Common stock conversion requires 'shareholder approval'**. Nailed on the document, "We plan to get approval from special shareholders' meeting, but there is no guarantee." Until approval, conversion is not possible, but in fact, approval is highly likely. However, even after approval, 'pouring out at once' may be restricted due to the beneficial ownership cap.
0 · Reply